NCT05515471View on ClinicalTrials.gov

Effect of SHR8058 on Signs and Symptoms of Dry Eye Disease Associated With Meibomian Gland Dysfunction

PHASE3CompletedINTERVENTIONAL

Enrollment

312

Participants

Timeline

Start Date

February 4, 2021

Primary Completion Date

September 7, 2021

Study Completion Date

September 7, 2021

Conditions

Treatment of Dry Eye Disease With Meibomian Gland Dysfunction

Interventions

DRUG

SHR8058 eye drops

DRUG

saline eye drops.

Trial Locations (1)

100730

Beijing Tongren Hospital, Beijing

All Listed Sponsors

lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY

NCT05515471 - Effect of SHR8058 on Signs and Symptoms of Dry Eye Disease Associated With Meibomian Gland Dysfunction | Biotech Hunter | Biotech Hunter